Protagonist Therapeutics, Inc. Common Stock

PTGX US74366E1029

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Annual Performance ¹

2021	2022	2023	2024	2025
74%	-69%	113%	65%	2%

Annual Insiders Turnover, USD ²

¹ annual and historical performance metrics are recalculated on a daily basis;
² represents the total value of insider transactions (both buying and selling);

Insider Activity

Person	Price	Shares	Total	Published	Completed
Waddill William D. O	64.25 USD	4,000 Sold	257,000 USD	22/09/2025	22/09/2025
Waddill William D. O	64.25 USD	4,000 Sold	257,000 USD	22/09/2025	22/09/2025
Waddill William D. O	64.25 USD	4,000 Sold	257,000 USD	22/09/2025	22/09/2025
Waddill William D. O	59.25 USD	4,000 Sold	237,000 USD	27/08/2025	27/08/2025
Patel Dinesh V Ph D CEO	54.78 USD	10,415 Sold	570,534 USD	25/07/2025	25/07/2025
Patel Dinesh V Ph D CEO	54.79 USD	17,520 Sold	959,921 USD	21/07/2025	23/07/2025
Patel Dinesh V Ph D CEO	55.05 USD	22,065 Sold	1,214,678 USD	21/07/2025	22/07/2025
Patel Dinesh V Ph D CEO	54.86 USD	12,859 Sold	705,445 USD	21/07/2025	21/07/2025
Molina Arturo Md CMO	57.03 USD	10,000 Sold	570,300 USD	09/06/2025	10/06/2025
Molina Arturo Md CMO	57.03 USD	10,000 Sold	570,300 USD	09/06/2025	10/06/2025

Load More

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Protagonist Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

Generate

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

• Insider Transaction Amount Distribution
• Insider Trading Seasonality
• Delta Correlation Analysis

 

Historical Performance

1M	3M	6M	1Y	3Y	5Y	All Time
-15%	2%	37%	43%	153%	136%	238%

Last	52W Low	52W High	All-Time Low	All-Time High	β
64.51	40.89	64.51	40.89	64.51

Company Insiders

Person / Entity	Transactions	Turnover, USD	Average, USD	First	Last
Patel Dinesh V Ph D	11	12,729,933.31	1,157,266.66	13/12/2023	25/07/2025
Gupta Suneel	3	5,760,429.98	1,920,143.33	09/01/2024	26/11/2024
Molina Arturo Md	12	5,630,387.92	469,198.99	15/11/2023	10/06/2025
Ali Asif	9	2,970,552.04	330,061.34	29/02/2024	22/04/2025
Waddill William D.	8	2,374,636.50	296,829.56	01/03/2024	22/09/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies ³

Name	ISIN	Ticker
Arrowhead Pharmaceuticals, Inc.	US04280A1007	ARWR

³ the firms where the current insiders have executed transactions.

Stock Advanced Metrics

Delta Correlation	subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4	subscribe 🔒

⁴ represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

⁵ a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.